首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of clinical hypertension

缩写:J CLIN HYPERTENS

ISSN:1524-6175

e-ISSN:1751-7176

IF/分区:2.5/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引978
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Joel M Neutel,Keith Rotenberg Joel M Neutel
Increasing systolic blood pressure and heart rate during the early morning results in increased myocardial oxygen demand. The use of beta blockers during this period may decrease cardiac workload, particularly in beta-blocker sensitive pati...
Katherine H Hendrix,Susan Mayhan,Brent M Egan Katherine H Hendrix
Dyslipidemic, hypertensive patients (N = 48,863) were stratified by gender, age, and angina (n = 2502) vs. nonangina (n = 46,358) status. Comparing 95% confidence intervals yielded significant differences in treatment and cardiovascular ris...
Suzanne Oparil,Andrew P Miller Suzanne Oparil
The prevalence, impact, and control of hypertension differ between the sexes in the US population. In addition, pregnancy, oral contraceptive use, and menopausal hormone therapy may influence blood pressure regulation in ways that have ther...
Marvin Moser,Thomas G Pickering,Wiliam C Cushman Marvin Moser
Following a hypertension symposium in New York City on February 2, 2005, a roundtable was convened to discuss the use of beta blockers in the management of hypertension. Dr. Marvin Moser, Clinical Professor of Medicine at the Yale Universit...
Samy I McFarlane,Domenic A Sica,James R Sowers Samy I McFarlane
Stroke is major public health problem leading to increased morbidity and mortality. Modifiable risk factors for stroke include hypertension, diabetes, atrial fibrillation, dyslipidemia, smoking, and alcohol abuse. Among these risk factors, ...
Joel Handler Joel Handler
Quality of life on antihypertensive therapy is an important consideration because clinicians are asked to initiate drug therapy and follow mostly asymptomatic patients for long periods of time on agents that are fairly equivalent in both bl...
Roy Blank,James LaSalle,Russell Reeves et al. Roy Blank et al.
The Gemini Study was a 14-week, open-label, non-comparative, office-based, multicenter trial to evaluate single-pill therapy in the treatment of concomitant hypertension and dyslipidemia. In addition to recommending lifestyle modifications,...